Your browser doesn't support javascript.
loading
節目: 20 | 50 | 100
结果 1 - 1 de 1
过滤器
添加過濾器








年份範圍
1.
文章 在 英语 | WPRIM | ID: wpr-812187

摘要

The present study was undertaken to evaluate the influence of the methanolic fruit extract of Momordica cymbalaria (MFMC) on PPARγ (Peroxisome Proliferator Activated Receptor gamma) and GLUT-4 (Glucose transporter-4) with respect to glucose transport. Various concentrations of MFMC ranging from 62.5 to 500 μg·mL(-1) were evaluated for glucose uptake activity in vitro using L6 myotubes, rosiglitazone was used as a reference standard. The MFMC showed significant and dose-dependent increase in glucose uptake at the tested concentrations, further, the glucose uptake activity of MFMC (500 μg·mL(-1)) was comparable with rosigilitazone. Furthermore, MFMC has shown up-regulation of GLUT-4 and PPARγ gene expressions in L6 myotubes. In addition, the MFMC when incubated along with cycloheximide (CHX), which is a protein synthesis inhibitor, has shown complete blockade of glucose uptake. This indicates that new protein synthesis is required for increased GLUT-4 translocation. In conclusion, these findings suggest that MFMC is enhancing the glucose uptake significantly and dose dependently through the enhanced expression of PPARγ and GLUT-4 in vitro.


Subject(s)
Biological Transport , Dose-Response Relationship, Drug , Fruit , Gene Expression , Glucose , Metabolism , Glucose Transporter Type 4 , Metabolism , Hypoglycemic Agents , Pharmacology , In Vitro Techniques , Insulin , Metabolism , Momordica , Muscle Fibers, Skeletal , PPAR gamma , Metabolism , Plant Extracts , Pharmacology , Protein Biosynthesis , Protein Synthesis Inhibitors , Pharmacology , Rosiglitazone , Thiazolidinediones , Pharmacology , Up-Regulation
搜索明细